Atlas Trials

Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse

Clinical trial NCT00069966 · UNKNOWN

Trial details

NCT number
NCT00069966
Sponsor
Theradex
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2003-04-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.